KG-LIME: predicting individualized risk of adverse drug events for multiple sclerosis disease-modifying therapy.
Jason PattersonNicholas P. TatonettiPublished in: J. Am. Medical Informatics Assoc. (2024)
Keyphrases
- multiple sclerosis
- clinical trials
- acute coronary syndrome
- disease progression
- decision support system
- adverse drug reactions
- patient data
- lesion segmentation
- experimental design
- decision making
- learning process
- magnetic resonance images
- expert systems
- risk factors
- brain mri
- white matter
- magnetic resonance
- image processing